Received Feb 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 2345B | — |
Expired product used; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 26-year-old male patient who received HAV (Havrix 1440 adult) (batch number 2345B, expiry date 02-FEB-2026) for prophylaxis. On 07-FEB-2026, the patient received the 1st dose of Havrix 1440 adult. On 07-FEB-2026, an unknown time after receiving Havrix 1440 adult, the patient experienced expired vaccine used (Verbatim: Expired product used). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.